Sort
39,280 grants matching “leukemia”
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
$521,480Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML
$521,464Yang Liu · Children'S Research Institute · U01 · FY2017 · CA
Longitudinal Tumor Monitoring with Nanodevices
$521,381Andrew Kummel · University Of California, San Diego · U54 · FY2007 · CA
Project 4: Secondary Cancers Among NF1 Cancer Survivors
$521,291Jean Nakamura · Indiana University Indianapolis · U54 · FY2018 · CA
Project 3
$521,211Branden S Moriarity · University Of Minnesota · P01 · FY2024 · CA
GENETICS AND MECHANISMS OF DLI EFFECTS FOLLOWING NON-MYELOBLATIVE HCT
$521,162David H Sachs · Massachusetts General Hospital · P01 · FY2008 · CA
Heme synthesis, use and trafficking during erythropoiesis
$520,914Janis L Abkowitz · University Of Washington · R01 · FY2020 · HL
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding
$520,895Lucas Ferrari De Andrade · Icahn School Of Medicine At Mount Sinai · R37 · FY2025 · CA
T-Cell Targeting for GVHD
$520,796Bruce R. Blazar · University Of Minnesota · R01 · FY2022 · HL
Chemical Inhibitors of 15-prostaglandin dehydrogenase Potentiate Hematopoietic Stem Cell Transplantation
$520,706Joseph M Ready · Ut Southwestern Medical Center · R01 · FY2017 · CA
Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
$520,653Dorothy A Sipkins · Duke University · R01 · FY2025 · CA
Training Program in Molecular Hematology
$520,652Nancy Berliner · Brigham And Women'S Hospital · T32 · FY2015 · HL
Project 2: Molecular Modulation of Chromatin and Nuclear Structure in Cancer
$520,651Jonathan D. Licht · Northwestern University At Chicago · U54 · FY2015 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES
$520,632Warren S Pear · University Of Pennsylvania · T32 · FY2015 · CA
The genomic pathogenesis of Follicular Lymphoma
$520,601Sami Nimer Malek · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
$520,533Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2014 · CA
Emergency Myelopoiesis in the Pathogenesis of Myeloid Malignancies
$520,512Emmanuelle Passegue · Columbia University Health Sciences · R01 · FY2024 · CA
Mechanism of combined 'epigenetic therapy' in myeloid malignancies
$520,405Steven D Gore · Johns Hopkins University · R01 · FY2007 · CA
Biostatistics Shared Resource
$520,389Karla V Ballman · Mayo Clinic Rochester · P30 · FY2025 · CA
Identification of small molecule modulators of mitochondrial creatine kinase 1
$520,361Eduard A. Sergienko · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2020 · CA
Development of P2Y Receptor Ligands
$520,344Kenneth Alan Jacobson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Quantitative Volume and Density Response Assessment: Sarcoma and HCC as a Model
$520,335Lawrence H Schwartz · Columbia University Health Sciences · U01 · FY2015 · CA
REGULATION OF NEUTROPHIL-SPECIFIC GENE EXPRESSIONS
$520,326Nancy Berliner · Yale University · P01 · FY2008 · HL
Role of HOTTIP/beta-catenin-HOXA9/PRMT1 axis in hematopoietic and leukemic stem cells
$520,285Suming Huang · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2022 · CA
Targeted Therapy for Lymphoid Malignancies
$520,184John C Byrd · Ohio State University · R01 · FY2014 · CA